跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GAVRETO 100 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
GAVRETO 100 MG CAPSULAS DURAS
Approved
STANDARD
GAVRETO 100 MG CAPSULAS DURAS
Blueprint Medicines (Netherlands) B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 9, 2021
Approval ID
1ea9f30c31f4c5b5
Company
Blueprint Medicines (Netherlands) B.V.
Type
Standard
Approval Details
Approval Id
1ea9f30c31f4c5b5
Drug Cima Aemps Name
GAVRETO 100 MG CAPSULAS DURAS
Register Number
1211555001
Holder Company Name
Blueprint Medicines (Netherlands) B.V.
Marketing Company Name
Blueprint Medicines (Netherlands) B.V.
Holder Company Detail Path
/organization/blueprint-medicines-netherlands-bv
Marketing Company Detail Path
/organization/blueprint-medicines-netherlands-bv
Authorization Date
2021-12-09
Dosage Form
CÁPSULA DURA
Dose
100 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Blueprint Medicines (Netherlands) B.V.
Company Detail Path
/organization/blueprint-medicines-netherlands-bv
Company Information
Pharmaceutical Company Name
Blueprint Medicines (Netherlands) BV
Country Name
Netherlands
Active Ingredients
PRALSETINIB
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 9, 2021
Approval ID
1ea9f30c31f4c5b5
Type
Standard
Back to CIMA-AEMPS Approvals